10X Genomics, Inc. current report, Q2 FY2025

Full document

10x Genomics, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 3, 2025. The meeting was conducted via live webcast. A quorum was established with holders of 108,937,350 shares representing approximately 87.7% of eligible votes present virtually or by proxy.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.

Material Changes and Voting Results

Three proposals were submitted to a vote at the Annual Meeting. All proposals were approved by the stockholders.

  • Proposal 1: Election of Directors
    • Sri Kosaraju: Approved with 189,313,724 votes for (87.4% of votes cast).
    • Shehnaaz Suliman: Approved with 168,973,468 votes for (77.8% of votes cast).
    • Both directors were elected to Class III seats with terms expiring at the 2028 annual meeting.
  • Proposal 2: Ratification of Independent Auditor
    • Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
    • Votes For: 215,766,816 (98.6% of votes cast).
  • Proposal 3: Executive Compensation (Say-on-Pay)
    • Stockholders approved the non-binding advisory vote on executive compensation.
    • Votes For: 164,321,765 (83.5% of votes cast).

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.

Key Facts for Investor Verification

  • Verify the specific term expiration dates for the newly elected directors (Class III, expiring 2028).
  • Confirm the engagement letter details with Ernst & Young LLP for the 2025 fiscal year.
  • Review the definitive proxy statement filed on April 14, 2025, for detailed executive compensation structures referenced in Proposal 3.
  • Note the significant "Against" vote for director Shehnaaz Suliman (27,595,026 votes) compared to Sri Kosaraju (7,243,542 votes).